Cidara’s CD388 Receives FDA Breakthrough Therapy Designation for Flu Prevention in High-Risk Read more
FDA Approves Boehringer Ingelheim’s JASCAYD as First PDE4B Inhibitor for Idiopathic Pulmonary Fibrosis Read more
LEAN Cell & Gene Summit Series Expands Following Successful Boston Debut Next event to take place in National Harbor, MD, November 6, 2025 Read more
Arthrosi Therapeutics Secures $153 Million in Series E Financing to Advance Late-Stage Gout Treatment Read more
Algen Biotechnologies and AstraZeneca Partner to Accelerate Immunology Drug Discovery Using AI and CRISPR Read more
NanoPhoria Bioscience Secures €83.5 Million Series A to Advance Novel Heart Failure Therapy Read more
Oragenics Partners with Receptor.AI to Expand Neurological Drug Pipeline Using AI-Powered Discovery Read more